tradingkey.logo

Medica device firm Encisione says Q3 sales hit by robot competition, to restructure to cut costs

ReutersFeb 4, 2026 12:14 PM


Overview

  • Medical device company's fiscal Q3 revenue fell 7.5% due to competition from surgical robots

  • Gross profit margin decreased significantly due to a large increase to the inventory reserve

  • Company is restructuring to reduce operating expenses, impact expected in Q4


Outlook

  • Encision expects revenue decrease to continue due to robotic surgeries replacing its procedures

  • Company restructuring to reduce operating expenses will impact fourth-quarter results


Result Drivers

  • SURGICAL ROBOTS - Revenue decline attributed to procedures performed by surgical robots replacing company procedures, per CEO Robert Fries

  • INVENTORY RESERVE - Gross profit margin decreased significantly due to a large increase to the inventory reserve

  • RESTRUCTURING - Company is restructuring and has reduced operating expenses substantially, impact expected in Q4


Key Details

Metric

Beat/Miss

Actual

Consensus Estimate

Q3 Product Revenue

$1.41 mln

Q3 Gross Profit

$543,000

Q3 Operating Expenses

$842,000

Q3 Operating Income

-$299,000

Press Release: ID:nACSJZSpza

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI